Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2023 Earnings Call Transcript

Page 2 of 2

Renae Cormier: Thank you, Dave. As we wrap up this conference call, we want to emphasize our ongoing commitment to delivering clinical benefit through earlier diagnosis of chronic cardiovascular conditions. The continued recognition of the value of this approach by our customers underscores the crucial role our technology plays for patients, physicians, facilities and payers in an evolving health care landscape. Moving forward, our primary objective remains setback to preserve and strengthen our current revenue opportunities and profitability within the chronic disease space with a focus on cardiovascular diseases. We appreciate your participation in today’s discussion, and thank you for your ongoing support. Goodbye.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Semler Scientific Inc.

Page 2 of 2